FRIDAY, Oct. 25, 2024 — As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
Prescriptions of this GLP-1 class of diabetes and…
You may also like
How AI Might Help Men Fighting Prostate Cancer
Iowa Resident Dies of Suspected Lassa Fever After Trip...
AI Might Help Pick Up Heart Trouble in Dogs
Childhood Attention Issues Show Links to Later Risk...
Colonoscopy Still Beats New Blood Tests at Spotting...
More Than Half of Heat Deaths Can Be Blamed on Global...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.